日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Radiographic progression-free survival as a surrogate endpoint for overall survival in first-line ARPi naïve metastatic castration-resistant prostate cancer

在未接受一线ARPi治疗的转移性去势抵抗性前列腺癌中，影像学无进展生存期可作为总生存期的替代终点

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf425
Castro, Elena; Paganelli, Stefanie; Wang, Di; Haltner, Anja; Niyazov, Alexander; Chang, Jane; Samjoo, Imtiaz A; Barata, Pedro C
肿瘤
前列腺癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Response to "Treatment Outcomes with Lanadelumab Every Two Weeks and Garadacimab Are Very Similar in Patients with Hereditary Angioedema"

对“每两周一次的 Lanadelumab 治疗效果与 Garadacimab 治疗遗传性血管性水肿患者的疗效非常相似”一文的回应

期刊:Drugs in Research & Development
影响因子:2.1
doi:10.1007/s40268-026-00536-x
Samjoo, Imtiaz A
发表日期：2026
文献求助 收藏

Talazoparib plus enzalutamide versus olaparib plus abiraterone acetate and niraparib plus abiraterone acetate for metastatic castration-resistant prostate cancer: a matching-adjusted indirect comparison

塔拉唑帕利联合恩扎卢胺对比奥拉帕利联合醋酸阿比特龙和尼拉帕利联合醋酸阿比特龙治疗转移性去势抵抗性前列腺癌：一项匹配调整的间接比较研究

期刊:Prostate Cancer and Prostatic Diseases
影响因子:5.8
doi:10.1038/s41391-024-00924-x
Castro, Elena; Wang, Di; Walsh, Sarah; Craigie, Samantha; Haltner, Anja; Nazari, Jonathan; Niyazov, Alexander; Samjoo, Imtiaz A
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Systematic literature review and meta-analysis of health state utility values in metastatic castration-resistant prostate cancer

对转移性去势抵抗性前列腺癌健康状态效用值的系统性文献综述和荟萃分析

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyae321
Castro, Elena; Figliuzzi, Rhett; Walsh, Sarah; Craigie, Samantha; Nazari, Jonathan; Niyazov, Alexander; Samjoo, Imtiaz A
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Comparative efficacy and safety of talazoparib plus enzalutamide and other first-line treatments for metastatic castration-resistant prostate cancer

比较他拉唑帕尼联合恩扎卢胺与其他一线治疗转移性去势抵抗性前列腺癌的疗效和安全性

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyae237
Castro, Elena; Ellis, Jenna; Craigie, Samantha; Haltner, Anja; Nazari, Jonathan; Niyazov, Alexander; Samjoo, Imtiaz A
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023

医疗决策中的间接治疗比较：2021-2023年全球肿瘤药物监管审批、报销和定价建议的重点回顾

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-03013-6
Igarashi, Ataru; Tanaka, Shiro; De Moor, Raf; Li, Nan; Hirozane, Mariko; Wu, David Bin-Chia; Hong, Li Wen; Yu, Dae Young; Hashim, Mahmoud; Hutton, Brian; Tantakoun, Krista; Olsen, Christopher; Fashami, Fatemeh Mirzayeh; Samjoo, Imtiaz A; Cameron, Chris
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Correction to: Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023

更正：医疗保健决策中的间接治疗比较：2021-2023年全球肿瘤药物监管审批、报销和定价建议的针对性审查

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-03087-2
Igarashi, Ataru; Tanaka, Shiro; De Moor, Raf; Li, Nan; Hirozane, Mariko; Wu, David Bin-Chia; Hong, Li Wen; Yu, Dae Young; Hashim, Mahmoud; Hutton, Brian; Tantakoun, Krista; Olsen, Christopher; Fashami, Fatemeh Mirzayeh; Samjoo, Imtiaz A; Cameron, Chris
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Real-world effectiveness of CDK4/6i in first-line treatment of HR+/HER2- advanced/metastatic breast cancer: updated systematic review

CDK4/6抑制剂一线治疗HR+/HER2-晚期/转移性乳腺癌的真实世界疗效：最新系统评价

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1530391
Harbeck, Nadia; Brufsky, Adam; Rose, Chloe Grace; Korytowsky, Beata; Chen, Connie; Tantakoun, Krista; Jazexhi, Endri; Nguyen, Do Hoang Vien; Bartlett, Meaghan; Samjoo, Imtiaz A; Pluard, Timothy
CDK4
肿瘤
HER2
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Real-world effectiveness and safety of CDK4/6i in elderly and BIPOC patients with HR+/HER2- advanced/metastatic breast cancer: an updated systematic literature review

CDK4/6抑制剂在老年及有色人种HR+/HER2-晚期/转移性乳腺癌患者中的真实世界疗效和安全性：一项更新的系统性文献综述

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1577075
Harbeck, Nadia; Brufsky, Adam; Grace Rose, Chloe; Korytowsky, Beata; Chen, Connie; Tantakoun, Krista; Jazexhi, Endri; Nguyen, Do Hoang Vien; Bartlett, Meaghan; Samjoo, Imtiaz A; Pluard, Timothy
CDK4
肿瘤
HER2
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Matching-adjusted indirect comparison of talazoparib plus enzalutamide versus abiraterone acetate and docetaxel in mCRPC

在转移性去势抵抗性前列腺癌（mCRPC）中，对他拉唑帕尼联合恩扎卢胺与醋酸阿比特龙联合多西他赛进行匹配调整的间接比较

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2471200
Castro, Elena; Wang, Di; Walsh, Sarah; Craigie, Samantha; Haltner, Anja; Nazari, Jonathan; Niyazov, Alexander; Samjoo, Imtiaz A
肿瘤
前列腺癌
肿瘤免疫
CRP
发表日期：2025
文献求助 收藏